+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years - 65Years
All Genders
ID07059325

Accelerated Left Prefrontal Transcranial Magnetic Stimulation for Functional Seizures Open-Label Study on Feasibility, Tolerability, and Early Effects

Led by Medical University of South Carolina · Updated on 2026-09-28

30

Participants Needed

1

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the feasibility, tolerability, and preliminary effects of an accelerated intermittent theta burst stimulation a-iTBS-rTMS protocol targeting the left dorsolateral prefrontal cortex for people with Psychogenic Non-Epileptic Seizures PNES or Seizure-Type Functional Neurologic Disorder FND-seiz. This open-label study aims to offer a brain-based treatment that could be more acceptable and feasible than current psychological therapies, addressing the challenges and stigma associated with FND-seiz. The investigation also includes safety monitoring and expert input to ensure proper diagnosis and management during treatment. Participants will receive 6 to 10 TMS sessions per day, with each session delivering 600 pulses, totaling 6000 pulses daily over 3 to 5 treatment days. The goal is to complete 30 sessions 18,000 pulses targeting the left dorsolateral prefrontal cortex at a specific brain location called Beam F3. This accelerated treatment schedule is designed to mimic clinical practice and improve treatment feasibility for patients with FND-seiz. The protocol uses a MagVenture MagPro TMS device and includes a safety protocol developed with epilepsy and brain stimulation experts. During the study, participants will be assessed before treatment, throughout the 3 to 5-day treatment period, and at a 4-week follow-up visit. Researchers will monitor the number of treatment sessions completed, delivery patterns of TMS pulses, and any adverse events. They will also evaluate seizure frequency, stigma, quality of life, depression, PTSD, somatic symptoms, psychosocial functioning, psychological distress, and clinical impressions of improvement. These assessments aim to understand how TMS may affect both FND-seiz symptoms and related psychological conditions.

CONDITIONS

Brief Title

Accelerated TMS for Seizure-Type Functional Neurologic Disorders

Research Team

R

Recruitment Coordinator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here